Loading data for BLCO — first visit, this takes a few seconds.
Bausch + Lomb Corporation (BLCO)
NYSE: BLCO
· Real-Time Price · USD
17.20
-0.25 (-1.43%)
At close: Aug 19, 2026, 3:59 PM
17.20
+0.00%
After-hours: 4:10 PM
Bausch + Lomb Corporation (BLCO) Stock Price, Analysis & Data
-1.43% (1D)
| Bid | n/a |
| Market Cap | 6.14B |
| Revenue (ttm) | 5.32B |
| Net Income (ttm) | -171M |
| Beta | 0.55 |
| EPS (ttm) | -0.48 |
| PE Ratio (ttm) | n/a |
| Forward PE | 15.73 |
| P/B (ttm) | 0.95 |
| P/S (ttm) | 1.15 |
| Earnings Date | Oct 28, 2026 |
| Ask | n/a |
| Volume | 365,214 |
| Avg. Volume (20D) | 423,820 |
| Open | 17.33 |
| Previous Close | 17.45 |
| Day's Range | 17.04 - 17.46 |
| 52-Week Range | 13.77 - 18.91 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About BLCO
Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; a...
Industry Medical Instruments & Supplies
Sector Healthcare
IPO Date May 6, 2022
Employees 13,000
Stock Exchange NYSE
Ticker Symbol BLCO
Website https://www.bausch.com
Financial Performance
In 2025, Bausch + Lomb's revenue was 5.1B, an increase of 6.47% compared to the previous year's 4.79B. Earnings were -360M, an increase of 13.56%.
Financial StatementsEarnings Surprise
Bausch + Lomb has released their quarterly earnings on Jul 29, 2026:
Bausch + Lomb Corporation is scheduled to release its earnings on Oct 28, 2026, before market opens.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2



